The FDA has approved two gene-based treatments for sickle cell disease, including the first CRISPR-based treatment, opening a new era of treatments for genetic conditions and potentially providing a cure for people with the debilitating disease.
The post FDA approves two gene therapies for sickle cell, bringing hope to thousands with the disease appeared first on Dallas Examiner.
